Showing results (1-10 of 480) with videos related to
Sort By:
Pageof 48
Nihon Rinsho. Japanese Journal of Clinical Medicine|October 20, 2010
[Structure-guided molecular-targeting approach for development of AIDS therapeutics]Kenji Maeda, Hiroaki MitsuyaTuberculosis (Edinburgh, Scotland)|July 13, 2007
Development of therapeutics for AIDS: structure-based molecular targetingKenji Maeda, Hiroaki MitsuyaExpert Opinion on Emerging Drugs|April 27, 2012
CCR5 inhibitors: emergence, success, and challengesKenji Maeda, Debananda Das, Hirotomo Nakata, et al.The Journal of Biological Chemistry|December 6, 2001
Identification of amino acid residues critical for LD78beta, a variant of human macrophage inflammatory protein-1alpha, binding to CCR5 and inhibition of R5 human immunodeficiency virus type 1 replicationToshikazu Miyakawa, Kenshi Obaru, Kenji Maeda, et al.Current Opinion in Pharmacology|September 8, 2004
The current status of, and challenges in, the development of CCR5 inhibitors as therapeutics for HIV-1 infectionKenji Maeda, Hirotomo Nakata, Hiromi Ogata, et al.Scientific Reports|July 8, 2024
Deviated binding of anti-HBV nucleoside analog E-CFCP-TP to the reverse transcriptase active site attenuates the effect of drug-resistant mutationsYoshiaki Yasutake, Shin-Ichiro Hattori, Hiroki Kumamoto, et al.Antiviral Therapy|October 29, 2013
Delayed emergence of HIV-1 variants resistant to 4'-ethynyl-2-fluoro-2'-deoxyadenosine: comparative sequential passage study with lamivudine, tenofovir, emtricitabine and BMS-986001Kenji Maeda, Darshan V Desai, Manabu Aoki, et al.Scientific Reports|February 22, 2020
Structural features in common of HBV and HIV-1 resistance against chirally-distinct nucleoside analogues entecavir and lamivudineYoshiaki Yasutake, Shin-Ichiro Hattori, Noriko Tamura, et al.Biochemical and Biophysical Research Communications|January 17, 2019
Active-site deformation in the structure of HIV-1 RT with HBV-associated septuple amino acid substitutions rationalizes the differential susceptibility of HIV-1 and HBV against 4'-modified nucleoside RT inhibitorsYoshiaki Yasutake, Shin-Ichiro Hattori, Noriko Tamura, et al.Antimicrobial Agents and Chemotherapy|April 2, 2008
Potent synergistic anti-human immunodeficiency virus (HIV) effects using combinations of the CCR5 inhibitor aplaviroc with other anti-HIV drugsHirotomo Nakata, Seth M Steinberg, Yasuhiro Koh, et al.Pageof 48